This activity will begin with a review of the data for hypofractionation of regional nodal irradiation (RNI). That review will cover patients with intact breasts, post-mastectomy without reconstruction and post-mastectomy with reconstruction.

Brachytherapy is a critical component to the optimal management of locally advanced cervical cancer. However, due to many factors, its use was declining in the 2010s and when brachytherapy is omitted, patient outcomes are worse.

This program is designed to address the needs of a community practice physician and includes disease site reviews, interactive case-based discussions, a coding update and a scientific overview.

With this activity, ASTRO continues its series of challenging case panel sessions related to palliative radiotherapy for patients with advanced cancer.

Palliative radiotherapy (RT) is a foundation of the discipline and practically represents a significant portion of most practices. The standard protocols for palliative RT (8Gy x 1, 4Gy x 5, etc.) were pioneered almost 50 years ago, when systemic therapies were far less useful.

This activity provides an in-depth exploration of advanced quantitative imaging techniques for personalized radiotherapy, focusing on addressing barriers to clinical implementation and improving the management of lung toxicity.

Radiopharmaceutical therapies (RPTs) are increasingly utilized for treatment of prostate, neuroendocrine, thyroid and other cancers.

In this Research-Oriented Career Knowledge and Support (ROCKS) webinar, panelists with strong experience in various aspects for a competitive NIH R01 application will review the practical steps they took and insights they have to share about R01 grants.

In this Research-Oriented Career Knowledge and Support (ROCKS) webinar, participants will hear from five successful researchers within academic radiation oncology departments.  We will learn the opportunities and barriers associated with prioritizing academic research, and we will hear from leade

This activity discusses the use of PSMA PET for staging in high-risk prostate cancer. This includes when to order a PSMA PET, how to interpret it, common pitfalls and controversies of the scans.